Phenolcarboxylic acids from medicinal herbs exert anticancer effects through disruption of COX-2 activity

Phytomedicine

Volumn 21, Issue 11, 2014, Pages 1473-1482

  Tao, Li ^a   Wang, Sheng ^a   Zhao, Yang ^a   Sheng, Xiaobo ^a   Wang, Aiyun ^a   Zheng, Shizhong ^a   Lu, Yin ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Anticancer effects; COX 2; Phenolcarboxylic acids; Traditional Chinese medicine

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; ARGININE; BENZOIC ACID DERIVATIVE; CAFFEIC ACID; CARBOXYLIC ACID DERIVATIVE; CELECOXIB; CINNAMIC ACID DERIVATIVE; CYCLOOXYGENASE 2; GALLIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PHENOL DERIVATIVE; PROSTAGLANDIN E2; ROSMARINIC ACID; SALVIANOLIC ACID B; SERINE; ANTINEOPLASTIC AGENT; CARBOXYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; HERBACEOUS AGENT; PTGS2 PROTEIN, HUMAN;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME INHIBITION; FEMALE; HERB; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; MEDICINAL PLANT; METABOLISM; METASTASIS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARBOXYLIC ACIDS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MICE, INBRED BALB C; NEOPLASM METASTASIS; PLANTS, MEDICINAL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84906939131     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2014.05.001     Document Type: Article

References (32)

1. N. Arber, C.J. Eagle, J. Spicak, I. Racz, P. Dite, J. Hajer, M. Zavoral, M.J. Lechuga, P. Gerletti, J. Tang, R.B. Rosenstein, K. Macdonald, P. Bhadra, R. Fowler, J. Wittes, A.G. Zauber, S.D. Solomon, and B. Levin Celecoxib for the prevention of colorectal adenomatous polyps N. Engl. J. Med. 355 2006 885 895 (Pubitemid 44315981)
2. A.T. Chan, S. Ogino, and C.S. Fuchs Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 N. Engl. J. Med. 356 2007 2131 2142 (Pubitemid 47010839)
3. X. Chen, J. Guo, J. Bao, J. Lu, and Y. Wang The anticancer properties of salvia Miltiorrhiza Bunge (Danshen): a systematic review Med. Res. Rev. 2013
4. H. Clevers Colon cancer - understanding how NSAIDs work N. Engl. J. Med. 354 2006 761 763 (Pubitemid 43247150)
5. G. Dannhardt, and W. Kiefer Cyclooxygenase inhibitors - current status and future prospects Eur. J. Med. Chem. 36 2001 109 126 (Pubitemid 32304514)
6. M. Dohadwala, R.K. Batra, J. Luo, Y. Lin, K. Krysan, M. Pold, S. Sharma, and S.M. Dubinett Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion J. Biol. Chem. 277 2002 50828 50833 (Pubitemid 36042248)
7. Z.Y. Gao, H. Xu, D.Z. Shi, C. Wen, and B.Y. Liu Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine J. Ethnopharmacol. 141 2012 578 583
8. S. Gately, and W.W. Li Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy Semin. Oncol. 31 2004 2 11 (Pubitemid 38879409)
9. J.K. Gierse, J.J. McDonald, S.D. Hauser, S.H. Rangwala, C.M. Koboldt, and K. Seibert A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors J. Biol. Chem. 271 1996 15810 15814 (Pubitemid 26225362)
10. A. Greenhough, H.J. Smartt, A.E. Moore, H.R. Roberts, A.C. Williams, C. Paraskeva, and A. Kaidi The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 2009 377 386
11. J.I. Kim, V. Lakshmikanthan, N. Frilot, and Y. Daaka Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome Mol. Cancer Res. 8 2010 569 577
12. K. Krysan, K.L. Reckamp, H. Dalwadi, S. Sharma, E. Rozengurt, M. Dohadwala, and S.M. Dubinett Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner Cancer Res. 65 2005 6275 6281 (Pubitemid 40994413)
13. R.E. Langley, S. Burdett, J.F. Tierney, F. Cafferty, M.K. Parmar, and G. Venning Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Br. J. Cancer 105 2011 1107 1113
14. F. Liao Herbs of activating blood circulation to remove blood stasis Clin. Hemorheol. Microcirc. 23 2000 127 131 (Pubitemid 32274595)
15. V. Limongelli, M. Bonomi, L. Marinelli, F.L. Gervasio, A. Cavalli, E. Novellino, and M. Parrinello Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition Proc. Natl. Acad. Sci. U. S. A. 107 2010 5411 5416
16. Y. Liu, H.J. Yin, D.Z. Shi, and K.J. Chen Chinese herb and formulas for promoting blood circulation and removing blood stasis and antiplatelet therapies Evid-based Complement. Alternat. Med.: eCAM 2012 2012 184503
17. X. Lu, and B. Li Exploration of the effect and mechanism of activating blood circulation and stasis-removing therapy on tumor metastasis Chin J. Integrative Med. 15 2009 395 400
18. E. Pace, L. Siena, M. Ferraro, M. Profita, P. Mondello, G. Chiappara, A.M. Montalbano, A. Giarratano, G. Bonsignore, and M. Gjomarkaj Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis Eur. J. Cancer 42 2006 2382 2389 (Pubitemid 44307619)
19. A. Pozzi, X. Yan, I. Macias-Perez, S. Wei, A.N. Hata, R.M. Breyer, J.D. Morrow, and J.H. Capdevila Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation J. Biol. Chem. 279 2004 29797 29804 (Pubitemid 38915863)
20. R. Ren, L. Ju, and Z. Chen Advances of studies on mechanisms of drugs for activating blood circulation and removing blood stasis in treatment of primary liver cancer. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan/sponsored by All-China Association of Traditional Chinese Medicine Acad. Traditional Chin. Med. 25 2005 304 309
21. L.H. Rome, and W.E. Lands Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs Proc. Natl. Acad. Sci. U. S. A. 72 1975 4863 4865
22. S.D. Sharma, S.M. Meeran, and S.K. Katiyar 36-Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors Mol. Cancer Therapeut. 9 2010 569 580
23. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA: Cancer J. Clin. 63 2013 11 30
24. D.L. Simmons, R.M. Botting, and T. Hla Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition Pharmacol. Rev. 56 2004 387 437 (Pubitemid 39096597)
25. S.D. Solomon, J.J. McMurray, M.A. Pfeffer, J. Wittes, R. Fowler, P. Finn, W.F. Anderson, A. Zauber, E. Hawk, and M. Bertagnolli Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention N. Engl. J. Med. 352 2005 1071 1080 (Pubitemid 40365348)
26. K.Y. Tan, C.B. Liu, A.H. Chen, Y.J. Ding, H.Y. Jin, and F. Seow-Choen The role of traditional Chinese medicine in colorectal cancer treatment Techniq. Coloproctol. 12 2008 1 6 discussion 6 (Pubitemid 351782224)
27. Y.P. Tang, J.A. Duan, X.S. Fan, E.X. Shang, S.L. Su, and A.W. Ding Effects of aromatic acids on stimulating blood circulation and removing blood stasis World Sci. Technol. 10 2008 38 42
28. R. Thomsen, and M.H. Christensen MolDock: a new technique for high-accuracy molecular docking J. Med. Chem. 49 2006 3315 3321 (Pubitemid 43830529)
29. J. Zhang, Y. He, M. Cui, L. Li, H. Yu, G. Zhang, and D. Guo Metabolic studies on the total phenolic acids from the roots of Salvia miltiorrhiza in rats Biomed. Chromatogr.: BMC 19 2005 51 59 (Pubitemid 40305316)
30. L.J. Zhang, L. Chen, Y. Lu, J.M. Wu, B. Xu, Z.G. Sun, S.Z. Zheng, and A.Y. Wang Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion Eur. J. Pharmacol. 643 2010 195 201
31. L. Zhou, Z. Zuo, and M.S. Chow Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use J. Clin. Pharmacol. 45 2005 1345 1359 (Pubitemid 41643896)
32. L.G. Zhou, and J.Y. Wu Development and application of medicinal plant tissue cultures for production of drugs and herbal medicinals in China Nat. Prod. Rep. 23 2006 789 810 (Pubitemid 44455390)